-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IqqIDxXiSbULQCXvcFlyfrp0PZyVOvgtY/ZLjPvMuYH/T51mKBN5HPp6HBlIjElA 4Fr/UpCt0ikneRf0E/s48w== 0001144204-08-009274.txt : 20080214 0001144204-08-009274.hdr.sgml : 20080214 20080214142800 ACCESSION NUMBER: 0001144204-08-009274 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080214 DATE AS OF CHANGE: 20080214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-83793 FILM NUMBER: 08613435 BUSINESS ADDRESS: STREET 1: 4225 EXECUTIVE SQUARE STREET 2: SUITE 460 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 457-5300 MAIL ADDRESS: STREET 1: 4225 EXECUTIVE SQUARE STREET 2: SUITE 460 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Bywater Resources, Inc DATE OF NAME CHANGE: 20060421 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Grasela Joseph CENTRAL INDEX KEY: 0001427205 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: BUSINESS PHONE: (858) 457-5300 MAIL ADDRESS: STREET 1: C/O TRANSDEL PHARMACEUTICALS, INC. STREET 2: 4225 EXECUTIVE SQUARE, SUITE 460 CITY: LA JOLLA STATE: CA ZIP: 92037 SC 13G 1 v103644_sc13g.htm
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 
SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2
 
Transdel Pharmaceuticals, Inc.
(Name of Issuer)
 
Common Stock, par value $0.001 per share
(Title of Class of Securities)
 
89363T 20 9
(CUSIP Number)
 
December 31, 2007
(Date of Event Which Requires Filing of this Statement)
 
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o
Rule 13d-1(b)
   
o
Rule 13d-1(c)
   
x
Rule 13d-1(d)


*  The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
     
CUSIP No. 89363T 20 9
13G
Page 2 of  5 Pages

 
 
 
 
 
 
 
 
 
 
1
NAMES OF REPORTING PERSONS
 
 
         
 
 
Joseph Grasela
 
 
 
 
 
 
 
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
o
 
 
 
(b)
o
 
 
  
 
 
 
 
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
         
 
 
United States
 
 
 
 
 
 
 
 
NUMBER OF
5
SOLE VOTING POWER
SHARES
 
 
 
BENEFICIALLY
 
1,171,875
 
OWNED BY
 
 
 
EACH
 
 
 
REPORTING
6
SHARED VOTING POWER
PERSON WITH
 
 
 
 
 
- 0 -
 
 
 
 
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
 
 
 
1,171,875
     
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
 
 
 
- 0 -
 
 
 
 
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
 
 
         
 
 
1,171,875
 
 
 
 
 
 
 
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
 
 
 
CERTAIN SHARES
 
o
 
 
 
 
 
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
 
 
 
 
 
 
 
 
8.5% (1)
 
 
 
 
 
 
 
 
 
 
 
12
TYPE OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
IN
 
 
 
 
 
 
 

(1)
Based upon an aggregate of 13,727,004 shares of common stock outstanding as of February 5, 2008, based upon the Issuer’s Registration Statement on Form SB-2, dated February 7, 2008.
 
 
     
CUSIP No. 89363T 20 9
13G
Page 3 of  5 Pages
 
Item 1.
    
     
 
(a)
Name of Issuer:
     
   
Transdel Pharmaceuticals, Inc.
     
 
(b)
Address of Issuer's Principal Executive Offices:
     
   
4225 Executive Square, Suite 460
   
La Jolla, California 92037
     
Item 2.
 
  
     
 
(a)
Name of Person Filing:
     
    Joseph Grasela
     
 
(b)
Address of Principal Business Office, or if none, Residence:
     
    4767 Ocean Boulevard #1001
    San Diego, California 92109
     
 
(c)
Citizenship:
     
    United States
     
 
(d)
Title of Class of Securities:
     
    Common Stock, par value $0.001 per share
     
 
(e)
CUSIP Number:
     
    89363T 20 9
     
Item 3.
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether
  the person filing is a:
       
 
(a)
o
Broker or dealer registered under Section 15 of the Act.
 
(b)
o
Bank as defined in section 3(a)(6) of the Act.
 
(c)
o
Insurance company as defined in section 3(a)(19) of the Act.
 
(d)
o
Investment company registered under section 8 of the Investment Company Act of
   
 
1940.
 
(e)
o
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
 
(f)
o
An employee benefit plan or endowment fund in accordance with Rule 13d-
   
 
1(b)(1)(ii)(F).
 
(g)
o
A parent holding company or control person in accordance with Rule 13d-
   
1(b)(1)(ii)(G).
 
(h)
o 
A savings association as defined in Section 3(b) of the Federal Deposit Insurance
     
Act;
 
(i)
o
A church plan that is excluded from the definition of an investment company under
     
Section 3(c)(14) of the Investment Company Act.
 
(j)
o 
Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
 
 
     
CUSIP No. 89363T 20 9
13G
Page 4 of  5 Pages
 
Item 4.
 
Ownership
     
 
(a)
 Amount beneficially owned:
     
    1,171,875
     
 
(b)
 Percent of Class:
     
    8.5%
     
 
(c)
 Number of Shares as to which the Reporting Person has:
     
 
 
(i)
Sole power to vote or to direct to vote: 1,171,875
 
 
(ii)
Shared power to vote or to direct to vote: 0
 
 
(iii)
Sole power to dispose or to direct the disposition of: 1,171,875
 
 
(iv)
Shared power to dispose or to direct the disposition of: 0
     
Item 5.
 
 Ownership of Five Percent or Less of a Class.
     
    Not Applicable.
     
Item 6.
 
 Ownership of More than Five Percent on Behalf of Another Person.
     
    Not Applicable.
     
Item 7.
 
 Identification and Classification of the Subsidiary Which Acquired the Security
     
    Being Reported on by the Parent Holding Company.
     
    Not Applicable.
     
Item 8.
 
 Identification and Classification of Members of the Group.
     
    Not Applicable.
     
Item 9.
 
 Notice of Dissolution of Group.
     
    Not Applicable.
     
Item 10.
 
 Certification.
     
    Not Applicable.
 
 
     
CUSIP No. 89363T 20 9
13G
Page 5 of  5 Pages
 
SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2008
  
   
  /s/ Joseph Grasela
 
Joseph Grasela
   
 
 -----END PRIVACY-ENHANCED MESSAGE-----